Lexeo Therapeutics Inc
LXEO4.830USD
+0.220+4.77%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
160.32MMarket Cap
LossP/E TTM
Lexeo Therapeutics Inc
4.830
+0.220+4.77%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-46.07%-21.72M
-102.60%-28.33M
-27.65%-17.81M
-52.77%-20.15M
19.09%-14.87M
15.91%-13.98M
-18.32%-13.95M
-19.37%-13.19M
-21.73%-18.38M
---16.63M
---11.79M
---11.05M
---15.09M
Net income from continuing operations
-50.61%-32.66M
-82.73%-25.92M
-46.65%-29.49M
-58.00%-21.24M
-16.21%-21.68M
2.68%-14.19M
-17.90%-20.11M
11.24%-13.44M
-49.24%-18.66M
---14.58M
---17.05M
---15.14M
---12.50M
Operating gains losses
5.25%501.00K
6.33%521.00K
10.65%509.00K
11.19%496.00K
6.50%476.00K
10.11%490.00K
34.50%460.00K
26.98%446.06K
6568.70%446.94K
--445.00K
--342.00K
--351.30K
--6.70K
Other non-cash items
-96.27%12.00K
-106.89%-23.00K
14.19%346.00K
9.95%339.00K
0.41%322.00K
12.46%334.00K
4.84%303.00K
5.95%308.33K
--320.67K
--297.00K
--289.00K
--291.00K
----
Change in working capital
67.91%6.73M
-376.00%-6.41M
62.14%7.38M
-93.81%-2.26M
813.20%4.01M
55.36%-1.35M
1.36%4.55M
-136.52%-1.16M
80.45%-561.98K
---3.02M
--4.49M
--3.19M
---2.87M
-Change in prepaid expenses
-80.10%-362.00K
-397.99%-2.08M
-513.64%-270.00K
556.90%861.00K
-138.33%-201.00K
184.40%698.00K
-109.95%-44.00K
-246.47%-188.44K
132.12%524.44K
---827.00K
--442.00K
--128.65K
---1.63M
-Change in other current assets
----
----
----
----
----
100.00%0.00
----
----
----
---1.00K
--3.00K
----
----
-Change in other current liabilities
---9.00K
---1.00K
100.00%0.00
38.30%11.00K
100.00%0.00
100.00%0.00
-155.56%-5.00K
1629.13%7.95K
82.88%-7.95K
---15.00K
--9.00K
--460.00
---46.46K
Cash from non-recurring investing activities
Cash from operating activities
-46.07%-21.72M
-102.60%-28.33M
-27.65%-17.81M
-52.77%-20.15M
19.09%-14.87M
15.91%-13.98M
-18.32%-13.95M
-19.37%-13.19M
-21.73%-18.38M
---16.63M
---11.79M
---11.05M
---15.09M
Investing cash flow
Net cash from continuing investing activities
----
-117.81%-13.00K
56.60%83.00K
458.97%218.00K
--193.00K
-31.78%73.00K
-86.75%53.00K
-82.30%39.00K
-100.00%0.00
--107.00K
--400.00K
--220.38K
--173.63K
Capital expenditures
----
-100.00%0.00
56.60%83.00K
458.97%218.00K
--193.00K
-31.78%73.00K
-86.75%53.00K
-82.30%39.00K
-100.00%0.00
--107.00K
--400.00K
--220.38K
--173.63K
Net cash flow from disposal of fixed assets
----
-100.00%0.00
2666.67%83.00K
446.15%213.00K
--185.00K
192.00%73.00K
-99.16%3.00K
-66.77%39.00K
-100.00%0.00
--25.00K
--356.00K
--117.38K
--173.63K
Net cash flow from intangible asset transactions
----
---13.00K
-100.00%0.00
--5.00K
--8.00K
-100.00%0.00
13.64%50.00K
-100.00%0.00
--0.00
--82.00K
--44.00K
--103.00K
----
Net cash flow from investment products
--15.60M
---93.60M
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
8182.90%15.60M
-128095.89%-93.58M
-56.60%-83.00K
-458.97%-218.00K
---193.00K
31.78%-73.00K
86.75%-53.00K
82.30%-39.00K
100.00%0.00
---107.00K
---400.00K
---220.38K
---173.63K
Financing cash flow
Cash flow from continuous financing activities
-99.99%11.00K
-100.10%-97.00K
-101.84%-72.00K
407.74%291.00K
91083.17%88.65M
123644.44%100.07M
11277.14%3.91M
-292.93%-94.56K
-138.06%-97.44K
---81.00K
---35.00K
--49.01K
--255.99K
Net cash flow from debt Issuance/repayment
-45.87%-159.00K
-10.48%-116.00K
-102.85%-111.00K
28.45%-74.00K
0.53%-109.00K
2.78%-105.00K
10913.89%3.89M
-444.33%-103.42K
---109.58K
---108.00K
---36.00K
---19.00K
--0.00
Net cash flow from common stock issuance/repurchase
-99.81%170.00K
---4.00K
--0.00
---54.00K
--88.75M
----
----
----
----
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
100.00%0.00
-100.00%0.00
--0.00
-100.00%0.00
---1.00K
--1.00K
----
--20.53K
Proceeds from stock option exercised by employees
----
--23.00K
30.00%39.00K
4628.05%419.00K
-17.61%10.00K
-100.00%0.00
--30.00K
-87.07%8.86K
-94.84%12.14K
--28.00K
--0.00
--68.54K
--235.46K
Net cash flow from other financing activities
----
----
----
----
----
--100.18M
---11.00K
----
----
----
----
---529.00
----
Net cash from non-recurrent financing activities
Net cash from financing activities
-99.99%11.00K
-100.10%-97.00K
-101.84%-72.00K
407.74%291.00K
91083.17%88.65M
123644.44%100.07M
11277.14%3.91M
-292.93%-94.56K
-138.06%-97.44K
---81.00K
---35.00K
--49.01K
--255.99K
Net cash flow
Beginning cash balance
-69.32%38.27M
314.13%160.27M
265.30%178.23M
219.26%198.31M
54.76%124.72M
-60.27%38.70M
-55.49%48.79M
-48.60%62.12M
-40.68%80.59M
--97.40M
--109.63M
--120.85M
--135.86M
Current period cash flow changes
-108.30%-6.11M
-241.84%-122.01M
-78.01%-17.96M
-50.69%-20.08M
498.39%73.59M
611.58%86.02M
17.46%-10.09M
-18.74%-13.32M
-23.05%-18.47M
---16.81M
---12.22M
---11.22M
---15.01M
Ending cash balance
-83.78%32.16M
-69.32%38.27M
314.13%160.27M
265.30%178.23M
219.26%198.31M
54.76%124.72M
-60.27%38.70M
-55.49%48.79M
-48.60%62.12M
--80.59M
--97.40M
--109.63M
--120.85M
Free cash flow
-44.20%-21.72M
-101.55%-28.33M
-27.76%-17.89M
-53.97%-20.37M
18.04%-15.06M
16.01%-14.05M
-14.87%-14.00M
-17.38%-13.23M
-20.35%-18.38M
---16.73M
---12.19M
---11.27M
---15.27M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
